ATOS

Atossa Therapeutics, Inc. - Common Stock (ATOS)

About Atossa Therapeutics, Inc. - Common Stock (ATOS)

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Details

Daily high

$2.38

Daily low

$2.22

Price at open

52 Week High

$19.35

52 Week Low

$1.70

Market cap

22.2M

Dividend yield

Volume

208

Avg. volume

44,811

P/E ratio

-.51

Atossa Therapeutics, Inc. - Common Stock News